Abstract
The transplantation of hematopoietic stem cells (HSCs) is regarded to be a potential approach for promoting the repair of damaged organs. Here, we investigated the influence of hematopoietic stem cells on progressive hair cell degeneration after cochlear ischemia in gerbils. Intrascalar injection of HSCs prevented Ischemia-induced hair cell degeneration and ameliorated hearing impairment. The administration of HSCs apparently augmented the upregulation of ischemia-induced GDNF, which is proved to inhibit ischemic cochlear damage. A tracking study revealed that HSCs injected into cochlear were retained in the perilymphatic space of the cochlea, although they neither transdifferentiated into cochlear cell types nor fused with injured hair cells. These results suggested that HSCs have therapeutic potential by preventing ischemia-induced hearing loss, probably through their paracrine effects. We concluded that the direct administration of HSCs into the perilymphatic space can be a new therapeutic strategy for sudden-onset hearing loss due to cochlear ischemia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
